Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOBLE: Fish-Oil-Based Lipid Emulsion in Moderate COVID-19
NCT04957940Phase 3Completed
- Sponsor
- Assiut University
- Start
- Jul 2021
- Primary completion
- Sep 2021
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of SMOFlipid in coronavirus disease 2019 (COVID-19), sponsored by Assiut University. Started Jul 2021; status: completed.
02
Drugs
SMOFlipid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04957940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04957940.